Article
Therapeutic interleukin-2 rewires skeletal-immune circuits to reverse postmenopausal bone loss
2026-01-08
Abstract excerpt
Postmenopausal osteoporosis results from excessive osteoclast activity, but the immune circuits that limit osteoclastogenesis in the bone marrow remain poorly understood. Here, we tested a clinically accessible immunotherapy low-dose interleukin-2 (IL-2) as a therapeutic intervention in mice with established ovariectomy-induced bone loss, integrating microcomputed tomography imaging, single-cell transcriptomics, g...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bc144c8-a0f2-53cc-b591-3c4f1244425b
- DOI
- 10.64898/2026.01.07.696511
